Texas Oncology-DFW — Dallas, Texas

Texas Oncology-DFW is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-DFW has participated in 2 clinical trials.

Therapeutic areas: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Sutro Biopharma, Inc., Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-DFW?

Texas Oncology-DFW has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-DFW conducted?

Texas Oncology-DFW has 2 clinical trials on record. Their work covers Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Is Texas Oncology-DFW accredited by Crixeo Health?

Texas Oncology-DFW has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-DFW?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.